Debra Friedman, M.D., is E. Bronson Ingram Professor of Pediatric Oncology and director of pediatric hematology and oncology at Vanderbilt University Medical Center. Her interests lie in supportive oncology during cancer therapy and in long-term outcomes for cancer survivors, as well as in the design of novel therapeutic protocols for childhood cancer to decrease adverse long-term effects of therapy. An internationally recognized expert in cancer survivorship, she participates in projects that evaluate best practices and innovative models of care.